Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia.

MLA

Marchetti, Matteo, et al. “Managing Argatroban in Heparin‐induced Thrombocytopenia: A Retrospective Analysis of 729 Treatment Days in 32 Patients with Confirmed Heparin‐induced Thrombocytopenia.” British Journal of Haematology, vol. 197, no. 6, June 2022, pp. 766–90. EBSCOhost, https://doi.org/10.1111/bjh.18120.

APA

Marchetti, M., Barelli, S., Gleich, T., Gomez, F. J., Goodyer, M., Grandoni, F., & Alberio, L. (2022). Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia. British Journal of Haematology, 197(6), 766–790. https://doi.org/10.1111/bjh.18120

Chicago

Marchetti, Matteo, Stefano Barelli, Tobias Gleich, Francisco J. Gomez, Matthew Goodyer, Francesco Grandoni, and Lorenzo Alberio. 2022. “Managing Argatroban in Heparin‐induced Thrombocytopenia: A Retrospective Analysis of 729 Treatment Days in 32 Patients with Confirmed Heparin‐induced Thrombocytopenia.” British Journal of Haematology 197 (6): 766–90. doi:10.1111/bjh.18120.